May 2016 VOL 7, NO 4


Letters from Lillie

Celebrating 1 Year of CONQUER: the patient voice

Lillie D. Shockney, RN, BS, MAS 

Dear Navigators, The landscape of cancer care has evolved tremendously over the past decade in every aspect: research targets, available treatments, management strategies, and even the makeup of the oncology [ Read More ]

Original Research

Development and Evaluation of a Technology-Enhanced Interdisciplinary Navigation Program for Low-Income Breast
Cancer Patients

Kathy J. Helzlsouer; Susan E. Appling; Susan Scarvalone; Shannon Manocheh; Ryan MacDonald; Lisa Gallicchio; Dawn Henninger; Arti P. Varanasi 

Background: Navigators have the potential to help overcome barriers that interfere with cancer treatment adherence, but their widespread use is economically challenging, especially in rural and low-resource communities. A centrally [ Read More ]

Original Research

A Feasibility Study of a Virtual Navigation Program for Low-Income Breast Cancer Patients

Kathy J. Helzlsouer; Susan E. Appling; Susan Scarvalone; Shannon Manocheh; Ryan MacDonald; Lisa Gallicchio; Dawn Henninger; Arti P. Varanasi 

Background: Socioeconomic disparities negatively impact completion of adjuvant breast cancer treatment. Navigation programs may improve treatment completion but may not be accessible to all patients, especially in low-resource communities. Objective: [ Read More ]

Learning Guide

Basics of Patient Navigation

Kamilah Konrad, LMSW 

Patient navigation addresses barriers to care and enables patients to be screened for cancer and complete cancer-related care as recommended by their healthcare providers.1 Although the details of how patient [ Read More ]

Clinical Trials Tracker

Select Ongoing Trials Currently Enrolling Patients with Multiple Myeloma

The following are a selection of key clinical trials that are currently recruiting patients for inclusion in investigations of new therapies and new regimens of available therapies for patients with [ Read More ]

Evidence into Practice

Continuum of Care and Care Transitions

Cheryl Bellomo, RN, MSN, OCN, CN-BN, and Pamela Goetz, BA 

The scope of navigation has evolved from the Freeman model of community outreach and prevention to spanning the entire continuum of care for oncology patients. Navigators help individuals overcome barriers [ Read More ]

Evidence into Practice

National Cancer Institute Community Cancer Centers Program Navigation Assessment Tool

As all navigation programs are built uniquely, we encourage you to rate your program as you feel appropriate. The purpose of this form is not to gauge one program against [ Read More ]

Evidence into Practice

Novice Navigator: A Case Study on the Complexities of Care Coordination

Morgan Finn, RN; Kimberly Foster, MBA, BSN, RN; Marian E. Gilmore, RN, OCN; Pamela Goetz, BA; Barbara R. McHale, RN, BS, OCN, CBCN 

The case study for this discussion highlights the complexities of care coordination when patients arrive unprepared physically or mentally for the recommended medical treatments as determined by guidelines. It also [ Read More ]

Evidence into Practice

Seasoned Navigator: A Case Study on Care Transitions in Genomic Testing and Timely Treatment Decision-Making

Cheryl Bellomo, RN, MSN, OCN, CN-BN; Deborah Christensen, RN, BSN, HNB-BC; Tricia Strusowski, RN, MS 

Along with the diagnosis of breast cancer comes many decisions regarding treatment options. Oncotype DX, a genomic/gene expression assay, provides quantitative assessment of chemotherapy benefit and risk of distant recurrence [ Read More ]

Evidence into Practice

Continuum of Care and Care Transitions: A Combined Conclusion from Novice and Seasoned Navigators

Cheryl Bellomo, RN, MSN, OCN, CN-BN, and Pamela Goetz, BA 

The role of the navigator along the continuum of care is bidimensional in nature with a patient-centered (empowerment with education and knowledge) and health system (multidisciplinary) orientation to deliver timely, [ Read More ]

Reimbursement

Anthem’s Response Survivorship Medicine: Reimbursement Based on Care Coordination and Patient Outcomes

Chase Doyle 

Survivorship medicine has never been in more demand, but questions regarding reimbursement remain. According to Jennifer Malin, MD, PhD, Staff Vice President, Clinical Strategy, Anthem, if cancer survivorship models are [ Read More ]

Survivorship

A New Paradigm for Survivorship Care: Assessing the Patient’s Priorities

Chase Doyle 

A new paradigm of survivorship care is needed that attempts to balance the patient’s total well-being against the often toxic treatment of the disease, suggests Deborah Korenstein, MD, Director of [ Read More ]

Survivorship

Decision Aids: Facilitating Communication with Cancer Survivors

Chase Doyle 

Linking physicians and patients is a major undertaking, but given the ubiquity of smartphone technology and the rise in app development, the healthcare industry is poised to leverage advances in [ Read More ]

Survivorship

Multidisciplinary Component of Survivorship Care

Chase Doyle 

The American Society of Clinical Oncology (ASCO) maintains that a multidisciplinary team (MDT) is the cornerstone of quality care, yet despite incentives and interest, little is known about how teams [ Read More ]

Financial Toxicity

New Grading System Shows Impact of Financial Toxicity on Health-Related Quality of Life

Chase Doyle 

Researchers in Chicago have developed a financial toxicity grading system based on independent and clinically meaningful changes in health-related quality of life. According to data presented at the 2016 Cancer [ Read More ]